| Association of treatment with nirmatrelvir and the risk of post–COVID-19 condition Y Xie, T Choi, Z Al-Aly JAMA Internal Medicine 183 (6), 554-564, 2023 | 211 | 2023 |
| Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras MD Yan Xie, Ph.D., Taeyoung Choi, M.S., and Ziyad Al-Aly The New England Journal of Medicine, 2024 | 88 | 2024 |
| Risk of death in patients hospitalized for COVID-19 vs seasonal influenza in fall-winter 2022-2023 Y Xie, T Choi, Z Al-Aly Jama 329 (19), 1697-1699, 2023 | 85 | 2023 |
| Molnupiravir and risk of post-acute sequelae of covid-19: cohort study Y Xie, T Choi, Z Al-Aly bmj 381, 2023 | 83 | 2023 |
| Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study Y Xie, T Choi, Z Al-Aly The Lancet Infectious Diseases 24 (3), 239-255, 2024 | 57 | 2024 |
| Nirmatrelvir and the risk of post-acute sequelae of COVID-19 Y Xie, T Choi, Z Al-Aly MedRxiv, 2022.11. 03.22281783, 2022 | 48 | 2022 |
| the risk of post-acute sequelae of COVID-19 Y Xie, T Choi, ZN Al-Aly MedRxiv, 2022 | 30 | 2022 |
| Mortality in patients hospitalized for COVID-19 vs influenza in fall-winter 2023-2024 Y Xie, T Choi, Z Al-Aly Jama 331 (22), 1963-1965, 2024 | 19 | 2024 |
| Data analysis using representation theory and clustering algorithms S Alkhushayni, T Choi, D Alzaleq WSEAS Trans. Comput 19, 310-320, 2020 | 12 | 2020 |
| Mapping the effectiveness and risks of GLP-1 receptor agonists Y Xie, T Choi, Z Al-Aly Nature medicine, 1-12, 2025 | 3 | 2025 |
| Adverse cardiovascular and kidney outcomes in people with SARS-CoV-2 treated with SGLT2 inhibitors T Choi, Y Xie, Z Al-Aly Nature Communications Medicine 4 (1), 179, 2024 | | 2024 |
| Before vs During the JN. 1-Predominant Era Y Xie, T Choi, Z Al-Aly | | 2024 |
Ziyad Al-Aly, MDU.S. Department of Veterans Affairs and Washington University in St. LouisEmail được xác minh tại va.gov